Client News

InflaRx to Proceed with Pivotal Development for Vilobelimab in Hidradenitis Suppurativa with New Primary Endpoint

Diaccurate Acquires Clinical Stage Sole-in-Class Targeted Cancer Therapy from Merck

XPhyto Reports Successful Market Launch and Growing Demand for its 25-minute COVID-19 PCR Test COVID-ID Lab

RedHill Biopharma’s Opaganib Demonstrates Significant Decrease of Kidney Fibrosis

Newron Receives Fourth Tranche from Financing Agreement with European Investment Bank (EIB)

Avisa Diagnostics Appoints Dr. Richard Murray as Chief Medical Officer

MorphoSys and Incyte Announce the European Commission Approval of Minjuvi® (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

HepaRegeniX initiates first-in-man Phase 1 trial for its lead MKK4 inhibitor HRX 0215

InflaRx Announces Positive Data from Second Interim Analysis of Ongoing Phase IIa Open Label Study with Vilobelimab in Pyoderma Gangraenosum

InflaRx to Present at the BTIG Virtual Biotechnology Conference